Tsai Chen Lung - 30 Jun 2026 Form 4 Insider Report for CapsoVision, Inc (CV)

Reporting relationship: Director
Issuer ticker: CV
Reported as of: 30 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 01 Jul 2026, 20:19:11 UTC
Prior SEC filing: 23 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Kang-Huai (Johnny) Wang, Attorney-in-Fact for Tsai Chen Lung

Key filing fact

Tsai Chen Lung filed Form 4 for CapsoVision, Inc (CV) on 01 Jul 2026.

Key facts

This page summarizes Tsai Chen Lung's Form 4 filing for CapsoVision, Inc (CV).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 01 Jul 2026, 20:19.

Change

Previous filing in this sequence was filed on 23 Mar 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001307275 Primary reporting owner

Tsai Chen Lung

Relationship: Director
Address: C/O CAPSOVISION, INC., 18805 COX AVENUE, SUITE 250, SARATOGA
Signature: /s/ Kang-Huai (Johnny) Wang, Attorney-in-Fact for Tsai Chen Lung
Signature date: 01 Jul 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CV transaction

Common Stock

Options Exercise

Transaction value
Shares: +2,022
Change %: +70%
Price: $7.58^*
Shares after: 4,929
Date: 30 Jun 2026
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CV transaction Derivative

Restricted Stock Unit (RSU)

Options Exercise

Transaction value
Shares: -2,022
Change %: -50%
Price: $0.000000^*
Shares after: 2,023
Date: 30 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 2,022
Exercise price: $0.000000
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Each Restricted Stock Unit (the "RSU") represents a contingent right to receive one share of the Issuer's common stock.

Footnote F2

The Restricted Stock Units (RSUs), the conversion of which are reported herein, were granted to the Reporting Person by the issuer as part of equity incentive grants made by the issuer on 3/19/2026 utilizing a fair market value (FMV) of a share of the issuers stock of $6.18. The RSU grant vests as to 50% of the RSUs subject to the award on June 30 of the applicable year and as to 50% of the RSUs subject to the award on December 31 of that year. This report reflects the vesting of one-half portion of the original RSU grant and the acquisition by the Reporting Person of the underlying shares.